论文部分内容阅读
目的探讨脑卒中合并肺部感染患者的细菌学、药敏试验特征及舒普深治疗疗效。方法选取脑卒中合并肺部感染患者186例,做痰培养及药敏试验,对其病原学特点及药敏状况进行分析,并应用舒普深治疗观察其疗效。结果脑卒中合并肺部感染多为革兰氏阴性杆菌感染占80%,舒普深对阴性杆菌敏感率高,临床疗效达80%。结论脑卒中合并肺部感染以阴性杆菌为多,多数细菌对舒普深敏感,舒普深临床疗效好,治疗过程未见明显副毒作用。
Objective To investigate the bacteriological and drug susceptibility characteristics of patients with stroke complicated with pulmonary infection and the therapeutic effect of Shu Pu-Shen. Methods A total of 186 patients with stroke complicated with pulmonary infection were selected for sputum culture and drug susceptibility test. The etiology and susceptibility of the patients were analyzed. The curative effect was observed by Shu Pu-Shen treatment. Results Most patients with stroke complicated with pulmonary infection accounted for 80% Gram-negative bacilli infection. The sensitivity rate of Shu Pu-Shen to negative bacilli was high, and the clinical efficacy reached 80%. Conclusions There are many negative bacilli in stroke complicated with pulmonary infection. Most of the bacteria are sensitive to shuopu, and Shu Pu deep clinical efficacy is good. No obvious side-effect is observed during the course of treatment.